BamSEC and AlphaSense Join Forces
Learn More

Madrigal Pharmaceuticals Inc.

NASDAQ: MDGL    
Share price (12/24/24): $312.00    
Market cap (12/24/24): $6.805 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 32 pages Material contract
12/34/56
EX-10.1
from 10-Q 21 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.1
from 8-K 20 pages Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan Originally Effective June 11, 2015 Amended and Restated Effective June 29, 2017 Amended and Restated Effective June 27, 2019 Amended and Restated Effective June 17, 2021 Amended and Restated Effective June 25, 2024
12/34/56
EX-10.3
from 10-Q 3 pages Supplemental Compensation Recovery Policy Madrigal Pharmaceuticals, Inc. Supplemental Compensation Recovery Policy
12/34/56
EX-10.2
from 10-Q 22 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.1
from 10-Q 21 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.20
from 10-K 14 pages Form of Madrigal Indemnification Agreement
12/34/56
EX-10.1
from 8-K 45 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.5
from 10-Q 8 pages Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.4
from 10-Q 10 pages Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.3
from 10-Q 8 pages Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.2
from 10-Q 15 pages Registration Rights Agreement
12/34/56
EX-10.12
from 10-K 10 pages Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.1
from 8-K 63 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.2
from 8-K 4 pages Amendment No. 2 to Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 56 pages Certain Confidential Information in This Exhibit Has Been Omitted and Replaced With “[***]” Because It Is Not Material and Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.1
from 10-Q 1 page Non-Employee Director Equity Compensation Policy
12/34/56
EX-10.7
from 10-Q 8 pages Madrigal Pharmaceuticals, Inc. __, 20
12/34/56
EX-10.1
from 10-Q 32 pages Note: Certain Information in This Agreement Has Been Redacted Because It (1) Is Not Material to Investors and (2) Would Likely Cause Competitive Harm if Publicly Disclosed. Bracket References Contained Herein Denote Portions of the Agreement That Have Been Redacted
12/34/56